Prognostic Role of HER2 Status and Adjuvant Trastuzumab Treatment in Lymph Node-Negative Breast Cancer Patients - a Retrospective Single Center Analysis.

Fokter Dovnik, Nina; Dovnik, Andraz; Cas Sikosek, Nina; Ravnik, Maja; Arko, Darja; Takac, Iztok

Fokter Dovnik, Nina; Dovnik, Andraz; Cas Sikosek, Nina; Ravnik, Maja; Arko, Darja; Takac, Iztok.

Afiliação

Fokter Dovnik N; Department of Oncology, University Medical Centre Maribor, Maribor, Slovenia, Maribor, Slovenia.
Dovnik A; University Clinical Department of Gynecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia, Maribor, Slovenia.
Cas Sikosek N; University Clinical Department of Gynecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia, Maribor, Slovenia.
Ravnik M; Department of Oncology, University Medical Centre Maribor, Maribor, Slovenia, Maribor, Slovenia.
Arko D; University Clinical Department of Gynecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia, Maribor, Slovenia.
Takac I; University Clinical Department of Gynecology and Perinatology, University Medical Centre Maribor, Maribor, Slovenia, Maribor, Slovenia; Faculty of Medicine, University of Maribor, Maribor, Slovenia.

Breast Care (Basel) ; 11(6): 406-410, 2016 Dec.

Article em En | MEDLINE | ID: mdl-28228707

Palavras-chave

Adjuvant therapy; Breast cancer; HER2 status; Prognosis; Trastuzumab

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Prognostic_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google